Giang V, Brar R, Sutherland C, Nolan S HIV treatment initiation and retention among individuals initiated on injectable opioid agonist therapy for severe opioid use disorder: a case series J Addict Med, 2020. PubMed

Reddon H, Kerr T, Milloy MJ Ranking evidence in substance use and addiction Int J Drug Policy, 2020. PubMed

Mitra S, Boyd J, Wood E, Grant C, Milloy MJ, DeBeck K, Kerr T, Hayashi K Elevated prevalence of self-reported unintentional exposure to fentanyl among women who use drugs in a Canadian setting: a cross-sectional analysis Int J Drug Policy, 2020. PubMed

Tobias S, Shapiro A, Wu H, Ti L Xylazine identified in the unregulated drug supply in British Columbia, Canada Can J Addict, 2020. Link

Mackay L, Ickowicz S, Hayashi K, Abrahams R Rooming-in and loss of child custody: key factors in maternal overdose risk Addiction, 2020. PubMed

Chayama KL, Ng C, McNeil R Calls for access to safe injecting supplies as a critical public health measure during the COVID-19 pandemic J Addict Med, 2020. PubMed

van Draanen J, Tsang C, Mitra S, Karamouzian M, Richardson L Socioeconomic marginalization and opioid-related overdose: a systematic review Drug Alcohol Depend, 2020. PubMed

Klimas J, McCracken R, Bassett K, Wood E Think twice: evidence-based opioid sparing approaches to pain management BC Med J, 2020. Link

Bach P, Robinson S, Sutherland C, Brar R Innovative strategies to support physical distancing among individuals with active addiction Lancet Psychiatry, 2020. PubMed

Marmel A, Bozinoff N Punitive discontinuation of opioid agonist therapy during incarceration Int J Prison Health, 2020. PubMed